Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Poised to Become Global Leader in Manufacture of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM) recently announced it had signed a definitive agreement to acquire 100% of BayMedica Inc., a U.S.-based private company specializing in the manufacture and commercialization of rare cannabinoids. InMed CEO Eric A. Adams described the acquisition as a transformative transaction for the company as it would give InMed a breadth of synthetic cannabinoid manufacturing capabilities. “BayMedica brings unparalleled cannabinoid manufacturing expertise in both chemical synthesis and biosynthesis together with industry veterans who have been pioneers in this space,” a recent article quotes Adams as saying. The article further notes that, once closed, the transaction will create a powerful combination. “It will make InMed a global leader in the manufacture of rare cannabinoids, with expertise in three distinct and complementary cannabinoid manufacturing approaches… At the same time, the combined company will continue to explore the therapeutic potential of cannabinoids and novel cannabinoid analogs for pharmaceutical drug development. It will also increase commercial sales of rare cannabinoids to the consumer health and wellness sector.”

To view the full article, visit https://cnw.fm/7rOGP

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (“CBN”), in diseases with high unmet medical need. The company is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based medicines. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW — As Millennials Shun Alcohol, Alcohol Firms Start Eyeing Cannabis Drinks Segment

Millennials have been at the forefront of change for quite a while now. They were the first generation to grow up with the internet, and they played a significant role in the development of e-commerce. They are also holding off on homeownership, are waiting longer to marry, and have fewer kids. They are not concerned with living the way past generations did; rather, they are doing their own thing, and society tends to follow in their steps. Now, the generation’s growing aversion to alcohol may very well revolutionize the beverage industry and elevate a burgeoning cannabis segment in the process.

The past few years have seen cannabis-infused drinks enjoy increasing popularity. With cannabis technology constantly improving, cannabis companies can now create smooth cannabis beverages of all kinds of flavors. Taking advantage of a growing movement that prefers to avoid alcohol, especially among millennials and the younger generation Z, these companies are offering these drinks as an alternative to alcoholic drinks. Even alcohol beverage brands such as Guinness and Heineken have noticed a decline in the demand for alcohol among the younger generations and have pivoted by offering low or even zero-alcohol beers.

According to data from the Centers for Disease Control (“CDC”) that was analyzed by research firm Cowen, there has been a 13% drop in binge drinking rates in states with legal cannabis markets with the rates of first-use cannabis increasing as binge-drinking rates reduced. Using this data as a base, Cowen projected that the cannabis market will grow from $50 billion in 2026 to $75 billion in 2030 while alcohol brands will see flat or slow growth.

However, the cannabis beverage segment is still quite small, making up just $174 million of the $11.3 billion worth of cannabis products sold in the United States in 2018, estimates from “Fortune Business Insights” show. One reason the segment is still quite small is that the technology required to make high-quality cannabis drinks is fairly new and, thanks to federal prohibition, plenty of companies have avoided cannabis beverages.

Furthermore, cannabis companies still struggle to infuse the substance into drinks, thanks to marijuana’s pungent aroma. This means that only beer, which has a stronger flavor compared to most wines, can successfully mask the aroma. There is also the risk that comes with cannabis edibles: they take up to an hour to kick in and, in the interim, there is a chance the consumer may overindulge as they wait for the effects to kick in.

Because of that, companies have taken to infusing drinks with an amount of THC that kicks in, peaks and fades at around the same rate as alcohol. Ultimately, only time will tell whether cannabis beverages will eventually replace alcohol, at least for millennials and gen Z.

The formulations by companies such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) may play a pivotal role in drawing more adults to the cannabis drinks segment due to the improved tech being deployed during the manufacturing process.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Schumer Reveals Key Senators Agree Cannabis Banking Will Be Addressed After Legalization

In a recent interview, Senate Majority Leader Chuck Schumer revealed that he and his colleagues who are working to advance a bill to legalize cannabis at the federal level have a consensus to not get involved in the marijuana banking legislation until more broad reforms are advanced. Schumer noted that he was open to exploring alternative ways to advance the banking reform if legislators were able to include social equity provisions of legalization, such as expungements for previous marijuana convictions, into the defense policy bill that the chamber will be discussing in the coming weeks.

The interview was conducted on the Psychoactive podcast by Ethan Nadelmann, who is the founder of Drug Policy Alliance.

The majority leader stated that there was an agreement between Sens. Cory Booker and Ron Wyden, who is chairman of the Senate Finance Committee, to block the banking bill, which would offer protection to financial institutions that work with state-legal marijuana businesses. That is, of course, until a legalization bill that was social equity centered was advanced.

The bipartisan bill, dubbed the SAFE Banking Act (Secure and Fair Enforcement), has a strong chance of being approved in Congress, having already been passed by the House of Representatives a few times now. The House is set to pass a separate legalization initiative, sponsored by Chairman Jerrold Nadler, that is similar to the proposal to end federal prohibition on cannabis, which Schumer is sponsoring.

In the interview, Schumer stated that letting the banking legislation be approved would only make it longer and harder to pass comprehensive reform. He explained that the suffering people had to endure wouldn’t be reduced simply because banks could be allowed to fund the growing and processing of marijuana, noting that the quickest way to approve the banking act as well as federally legalize cannabis would be together.

Schumer added that letting the banking legislation be approved would also make it harder to get more conservatives on the federal cannabis legalization bill. However, the majority leader didn’t eliminate the possibility of including some marijuana reform initiatives to the Senate’s version of the National Defense Authorization Act if other provisions focused on justice could be added.

The SAFE Banking Act was attached to this defense legislation, which lacks most of the social equity provisions that activists would like to see. Schumer did recognize that allowing banks to work with cannabis businesses without incurring penalties would allow some disadvantaged communities to obtain access to capital required to take part in the market.

In the long run, all cannabis industry actors, including Hero Technologies Inc. (OTC: HENC), would be better off after comprehensive federal legalization is implemented rather than the piecemeal approach being pushed by some industry advocates.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) Announces Entry into Strategic LOI

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) today announced its entry into a letter of intent (“LOI”) for the formation of a commercial relationship with Kingston Cannabis Inc. (“KCI”), a Health Canada licensed producer, to launch its cannabis-infused beverages through a co-packing arrangement with KCI. Under the arrangement, KCI’s affiliate, Kingston Aluminum Technologies Inc. (“KAT”) will provide custom designed aluminum packaging for Sproutly’s products. In addition, KCI and Sproutly will collaborate on the consumer evaluation of Sproutly’s formulations made using ingredients produced by the proprietary APP cannabis processing technology. “This relationship will allow us to launch our beverages made with our proprietary Infuz2O extract in distinct, environmentally friendly aluminum containers with unique internal coating for better preservation of cannabis products,” said Dr. Arup Sen, CEO and director of Sproutly. “Additionally, we will utilize KCI’s research license to test our product formulations and select our 3.0 beverages for features that are preferred in consumer products that will deliver a true-to-strain, whole-plant experience.”

To view the full press release, visit https://cnw.fm/DWB9b

About Sproutly Canada Inc.

Sproutly is positioning to become a leading supplier of proprietary cannabis ingredients, brands and customized formulations for the cannabis beverage and edibles marketplaces in Canada, Europe, Australia and other international markets. Its proprietary natural water-soluble Infuz 2 O and BioNatural Oils are designed to deliver true-to-strain whole-plant experiences to new consumers and cannabis connoisseurs alike, ushering in the Cannabis 3.0 revolution. Sproutly will enter into partnerships with globally established consumer brands to leverage existing customer bases, brand recognition and distribution networks to deliver this scientific breakthrough with speed and efficiency in major commercial territories around the world. For more information on Sproutly, please visit www.Sproutly.ca.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Enters Strategic Agreement to Produce Cannabis-Infused Beverages for Xebra Brands

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, today announced its entry into a white-label agreement with Xebra Brands Ltd., a rising player in the global cannabis beverage sector. Under the agreement, BevCanna will leverage its extensive experience in production and manufacturing at scale to distribute Xebra Brands’ Vicious Citrus(TM) THC Lemonade into the Canadian market. Selected as Xebra’s premier beverage to launch in Canada through consultation with provincial sales representatives, Vicious Citrus was noted as unique among cannabis beverages offered in Canada. Initially set to premiere in Spring 2022 in Ontario, British Columbia and Alberta, the anticipated line will subsequently expand to other provinces. “We’re thrilled to partner with BevCanna. Our extensive evaluation of potential co-packing partners in the Canadian space made it very evident that BevCanna is the best positioned and most qualified to consistently execute on Xebra’s beverage strategy,” said Rodrigo Gallardo, president of Xebra Brands. “BevCanna also has the ability to scale with us as we introduce more of our innovative brands to Canadian consumers.”

To view the full press release, visit https://cnw.fm/rdDHi

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with top U.S. cannabis beverage company Keef Brands. For more information about the company, visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at https://cnw.fm/BEV

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW — California Governor Enacts Bill Regulating Medical Cannabis Use in Hospitals

Last week, Gov. Gavin Newsom signed a legislation that would require hospitals to allow some patients to use medical cannabis. The governor of California signed the bill, having revealed that his concerns about an initial version of the bill that he had vetoed had been resolved.

The sponsor of the legislation, Sen. Ben Hueso, has been advocating for the measure to allow marijuana use in health facilities for patients with terminal illnesses over multiple sessions. Recently, Hueso sent a letter to the head of U.S. Department of Health and Human Services asking for clarification on whether the change in policy would threaten federal funding for medical facilities that allowed for the plant’s use.

Confusion about the potential implications for allowing for the consumption of cannabis in medical facilities was what prompted Newsom’s veto decision in 2019. Representatives from the governor’s office as well as the Department of Health and Human Services reached out to the senator asserting that they were looking into the matter.

The senator also received a letter from the Centers for Medicare and Medicaid Services, which stated that there were no federal regulations that addressed this particular issue, noting that the agency was not aware of any cases where funds had been pulled because a medical facility permitted its patients to use medical marijuana. In a press release, Hueso stated that he was confident that medical facilities had the authority to implement the legislation’s provisions while ensuring the safety of other employees, guests and patients of the medical facility as they were in compliance state laws and had received confirmation from the safeguards in the law as well as the Centers for Medicare and Medicaid Services.

However, there are a few restrictions that are included in the new law. For instance, vaping and smoking cannabis will be prohibited, and patients who receive treatment for emergency care will not be covered. The law also stipulates that health facilities will not be mandated to dispense or provide marijuana.

Newsom did not release a statement about the hospital legislation, which the governor’s office revealed that he’d signed, along with other unrelated bills. The governor has yet to sign legislation that would establish a regulatory framework for CBD sales derived from hemp. The legislation would also lift the ban on smokable hemp products.

In other news, activists in California have received clearance to start gathering signatures for a ballot measure for 2022 that would legalize psilocybin mushrooms in the state.

Now that patients in California can use medical cannabis within hospitable premises, it would be eye-opening to assess how beneficial enabling devices such as the RYAH Smart Inhaler made by RYAH Group Inc. (CSE: RYAH) can be for those patients.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — What Could the Future Hold for the UK’s CBD Sector?

The past couple of years have seen cannabidiol (“CBD”), a hemp extract that’s said to be filled with potent medicinal properties, become immensely popular in several territories across the world. Most countries with legal CBD markets legalized the hemp extract within the past decade, and as a whole, the industry still hasn’t been properly regulated. The United Kingdom’s CBD market is underregulated and over restricted, mirroring the legislative situation in most CBD markets around the world. However, around 6 million people in the UK have used CBD in some form, and the market is poised for explosive growth as even more people turn to CBD thanks to its medical applications.

So what can industry stakeholders and consumers expect from the UK’s CBD market in the years to come? For starters, we will likely see legislative reform of some sort as the market grows. Underregulated as it is, the CBD market has attracted unscrupulous companies looking to make a quick buck without any regard for their customers’ health. Regulation would clean up the industry, getting rid of the unethical players and their products while legitimizing the young CBD industry and attracting customers who would have otherwise avoided CBD. The recent Novel Foods legislation was a great start in regulating and legitimizing the CBD sector.

We can also expect regulations for the marketing of CBD products. Currently, CBD firms cannot directly advertise their products to consumers, meaning public awareness of CBD is pretty low. As the CBD market becomes more regulated, we will most likely see marketing regulation reform that will finally allow CBD companies to market their products to the public. This would in turn increase public awareness and attract more customers. The recent brand campaign by Cannaray CBD featuring Claudia Winkleman is an example of what CBD marketing could evolve into.

Personalized consultation may also become the norm. Just as America’s state-legal cannabis sector has “budtenders” who will answer customer questions about cannabis, UK’s CBD space will likely see an increase in consultation-dependent retail. CBD is a mystery to many people, and even for thos who are aware of it, knowledge is limited. Consultation and real-life sales support will be integral to helping customers understand CBD and its potential risks and benefits. This could result in the development of a countrywide network of CBD experts, healthcare professionals, scientists and general practitioners.

Product innovation will also become the norm. By its very nature, the CBD space is quite innovative with companies constantly working to develop high-quality CBD products. As such, there are now innumerable CBD-infused products, including pet care products and clothing. As the industry develops and matures, and customers learn more about CBD and its benefits, we can expect more product innovation and an increase in retail sales.

A number of parallels can be drawn from the CBD sector in the United Kingdom in comparison to the market in North America where companies such as Simply Sonoma Inc. are currently operating.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Achieves 13% QOQ Revenue Growth, Marks Remarkable Q2 2021

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently released its financial results for the second quarter of fiscal 2021. The company’s revenue was up 13% to $13.3 million, from $11.8 million in Q1 2021. In addition to a growth in revenue, RWB also received the Florida Department of Health, Office of Medical Marijuana Use approval; closed the acquisition of Acreage Florida; secured 20 double wide fully enclosed cultivation pods that will offer approximately 19,000 square feet of turn-key cultivation space; and completed the more comprehensive portion of Michigan’s two-step application process for medical marijuana licensing through its wholly owned operating subsidiary, RWB Michigan LLC. The company also closed the acquisition of an operational 45,000 SF greenhouse located on 4.7 acres of land in Apopka, Florida. Additionally, by the close of Q2 2021, RWB had completed over $52 million in financing transactions, retiring at least $7.7 million in debt. A recent article reads, “Q2 2021 was remarkable for RWB. Fiscal performance was impressive, and the company also made some strategic decisions and investments that guarantee its growth in performance as time progresses. The company is confident and optimistic about its performance in Q3 as well as the second half of 2021.”

To view the full article, visit https://cnw.fm/65fus

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Florida, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Alkaline88 Available in Sam’s Club This Fall

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, has announced that Sam’s Club will carry its Alkaline88(R) single-serve, one-Liter 12-pack offering in all 587 locations in the continental U.S. The product will be available by early November. The company stated that the agreement was possible because of its increased supply chain and production capabilities, including four new co-packers working to support WTER’s expected increase in volume. The single-serve, one-liter is the first of WTER’s products available in the all-important club channel, but the company hopes more of its offerings will follow. A leading membership warehouse club with nearly 600 clubs and millions of members in the United States and Puerto Rico, Sam’s Club offers a milestone moment for the company. “Alkaline88’s presence in Sam’s Club marks another milestone for our company and its stockholders,” said The Alkaline Water Company president and CEO Ricky Wright in the press release. “Sam’s Club is known for offering superior products and savings to their members. They are one of the largest membership warehouse clubs with millions of members nationwide. Beginning in November, members will find Deliciously Smooth(TM) Alkaline88 one-liters in a convenient 12-pack in their local Sam’s Club. The increased sales of our single serves this fiscal year will accelerate even more with this major win.” To view the full press release, visit https://cnw.fm/pE6kD About The Alkaline Water Company Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked Clean Beverage label. Quickly recognized as a growing lifestyle brand, Alkaline88 created the A88 Infused(TM) Beverage Division in 2018 to meet consumer demand for flavor-infused products under the A88 Infused brand. A88 Infused(TM) flavored water is available in six unique all-natural flavors, with new flavors coming soon. The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for the Alkaline88 and A88 Infused brands. To learn more about the company, please visit www.Alkaline88.com and www.TheAlkalineWaterCo.com. NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Launch of Global Clinical Trials

Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has announced its entry into an agreement to begin scientific clinical trials globally. According to the update, the focus of this study will be on the use of cannabinoids in patients suffering from fibromyalgia or chronic pain, with primary research sites located in the United States and the United Kingdom. By running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.), Flora Pharma expects to fast track traditional FDA and NHS timelines. “A paradigm shift is upon us where health care practitioners, researchers, patients and adult-use consumers are starting to understand, accept and embrace the therapeutic potential offered by phytocannabinoid-based medicine. As such, there is an urgent need for more research to better understand the molecular and biochemical effects of cannabis at the cellular level, to begin to apply its implications as a pharmaceutical drug,” said Dr. Annabelle Manalo-Morgan, director and lead scientific advisor of Flora Growth. “I’m extremely pleased that our team recognizes the importance and necessity of this research, not only to create and bring to market novel pharmaceutical cannabis products for patients around the world that are more efficacious and have a superior safety profile compared to traditional and incumbent pharmaceutical treatment options, but to also enhance long-term shareholder value. While this may seem like an ambitious and costly endeavor, we will be able to leverage our seed-to-sale platform to supply products for research and commercialization at incredibly favorable and competitive price points, while partnering with established organizations and institutions where additional funding subsidies are available.”

To view the full press release, visit https://cnw.fm/S1Vvl

About Flora Growth Corp.

Flora is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.